Trial record 1 of 1 for:    11-C-0100
Previous Study | Return to List | Next Study

Gemcitabine and CT-011 for Resected Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2013 by Georgia Regents University
Sponsor:
Information provided by (Responsible Party):
Samir N. Khleif, Georgia Regents University
ClinicalTrials.gov Identifier:
NCT01313416
First received: March 10, 2011
Last updated: October 15, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)